Fort Sheridan Advisors LLC Grows Position in Abbott Laboratories (NYSE:ABT)

Fort Sheridan Advisors LLC increased its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 3.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 12,584 shares of the healthcare product maker’s stock after buying an additional 402 shares during the quarter. Fort Sheridan […]

Related Keywords

Canada ,Lisad Earnhardt ,Raymond James ,Roberte Funck ,Abbott Laboratories ,Royal Bank ,Bradley Foster Sargent Inc ,Abbott Laboratories Company Profile ,Fort Sheridan Advisors ,Securities Exchange Commission ,Baird Financial Group Inc ,Guardian Wealth Management Inc ,Barclays ,Goldman Sachs Group ,Free Report ,Sheridan Advisors ,Asset Managment ,Wealth Management ,Financial Group ,Bayesian Capital Management ,Capital Management ,Get Free Report ,Exchange Commission ,Established Pharmaceutical Products ,Diagnostic Products ,Nutritional Products ,Visit Holdingschannel ,Abbott Laboratories Daily ,